Sentence examples for therapeutics compared with from inspiring English sources

The early protective effects on NMJ denervation and pNfH levels in serum could provide a quick screening approach for testing ALS therapeutics compared with the standard 5-month survival readout with SOD1G93A mice.

The patients with poorer outcome who have low levels of H3K4me2 and K18ac could perhaps benefit more from HDACi or require a different regimen of various epigenetic therapeutics compared to those with high levels of both histone modifications.

As clinical scoring, paw swelling, and plasma biomarkers were not very effective at detecting the differences between DMARD and non-DMARD therapeutics when compared with the histological assessment of inflammation, we used our NIR imaging agents to detect, image, and quantify the protease activity associated with the inflammatory cells in the affected tissue.

Additional advantages and limitations of these protein scaffolds as therapeutics compared to antibodies will be discussed.

Advantages and limitations of these protein scaffolds as therapeutics compared to antibodies are the subjects of a comprehensive discussion.

2, 7 Despite lower BTX-A dosages being used in cosmetic applications compared with therapeutics, there are now emerging reports of antibody-induced treatment failure in facial esthetics.

While the clinical administration of cell-based therapeutics often requires additional safeguarding and targeted delivery compared with traditional therapeutics, there is significant opportunity for minimally invasive device-assisted cell therapy to provide the physician with new regenerative options at the point of care.

Haemoglobin therapeutics under investigation are relatively short-lived compared with transfused red cells, placing potential limits on their future applications.

Within therapeutics research, the proportionately greater investment for tuberculosis compared with influenza seems appropriate, as does the tuberculosis-related focus within diagnostics.

Gobbi and Whyte (Gobbi and Whyte 2016) evaluated the medium-term clinical outcomes of cartilage repair using a single-stage technique of a hyaluronic acid-based scaffold (Hyalofast; Anika Therapeutics, Abano Terme, Italy) with bone marrow aspirate concentrate compared with microfracture technique.

The use of small organic molecules to modulate PPIs holds many advantages, because of the greater bioavailability of small molecules compared with nucleic acids, peptides or protein therapeutics, and the possibility of oral delivery.